healthcare distribution Industry size is expected to reach USD 1,384.59 Billion in 2028 and register a steady CAGR over the forecast period, according to latest analysis by Emergen Research. Steady market revenue growth can be attributed to increasing healthcare burden of chronic diseases among the growing geriatric population. Governments in developing countries are increasingly focusing on promoting healthcare utilization as a vital policy to enhance health outcomes and meet international obligations to make health services broadly accessible.
Advancements in research have resulted in development of next-generation and innovative and high-value or specialty medicines that are utilized to treat complex or rare chronic conditions. Advancements in specialty drugs coupled with increasing demand for traditional branded and generic drugs is expected to offer lucrative growth opportunities for various pharmaceutical distributors. These factors are driving growth of the healthcare distribution market. Moreover, utilization of specialty drugs to treat complex and chronic conditions such as auto immune disorders and cancers is expected to drive demand during the forecast period. Specialty drugs require unique logistics such as cold chain handling as most of these products are biologically derived. Rising need for advanced distribution centers to handle these logistical challenges is resulting in advancements in healthcare distribution systems in order to deliver specialty products safely and securely.
Research Methodology
Data triangulation and market breakdown
Research assumptions Research data including primary and secondary data
Primary data includes breakdown of primaries and key industry insights
Secondary data includes key data from secondary sources
Market Size – USD 808.13 Billion in 2020, Market Growth – at a CAGR of 7.0%, Market Trends – Increasing traction of personalized medicines
With all the data gathered and analyzed using SWOT analysis, there was a clearer picture of the competitive landscape of the global Healthcare Distribution market. Sources for the future market growth were uncovered and outlying competitive threats also surfaced. There was strategic direction eminent in the market and this shows in the key trends and developments studied. By getting market background and using current norms, policies, and trends of other leading markets for cross-references, market data was completed.
In October 2019, McKesson Corporation and Aetion announced a strategic collaboration, which is focused on advancing the use of Real-World Evidence (RWE) in cancer research in order to provide benefit to regulators, patients, payers, and the biopharma industry. The collaboration is expected to provide best-in-class solutions in multiple tumor types, including lung, breast, and melanoma cancers. The joint solutions consist of the Aetion Evidence Platform with data from McKesson’s iKnowMed oncology Electronic Health Record (EHR) system to power regulatory-grade outcomes research.
Subject matter experts conducting the study also take a closer look at the products at their development stage and in the pipeline to help business owners conclude on the business strategies that can lower their cost and promise great returns or profits. Strong emphasis on new launches, acquisition and mergers, collaboration, import and export status and supply chain management empowers the business evangelists, manufacturers and business owners build a robust strategy when it comes to making an investment.
Pharmaceutical product distribution services segment accounted for largest revenue share in 2020. Favorable investments on research and development activities for the development of pharmaceutical products is supporting growing demand and driving growth of the pharmaceutical product distribution services segment.
An extensive study of the product application and services conducted by subject matter experts assessing the Healthcare Distribution market will help product owners to make a wise decision. From analysing which products companies should produce, expand to how brands should position their product the study covers all that business owners require meeting the buyers’ requirement.
Retail pharmacies segment revenue is expected to expand at a rapid CAGR during the forecast period. Availability of health and wellness services in retail pharmacies and timely delivery of mail order pharmacies is driving rising consumer preference towards retail pharmacies.
A SWOT analysis is performed on the leading
companies engaged in the Healthcare Distribution market to offer a better understanding of the
strengths, opportunities, weaknesses, and threats of the leading companies. It
also covers production and consumption rate, the volatility of prices and
demands, market share, market size, global position, and market position of
each player.
#McKessonCorporation, #Cardinal #Health, #AmerisourceBergen #Corporation, Owens & Minor, Morris & Dickson Co. L.L.C., #CuraScript SD, FFF Enterprises, Inc., #Medline Industries, Attain Med, Inc., and #Dakota Drug.
Comments
Post a Comment